Artificial Intelligence-Enabled Facial Privacy Protection for Ocular Diagnosis: Development and Validation Study.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40632819.
- Also identified by DOI 10.2196/66873 and PMC identifier 12266301.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Facial biometric data, while valuable for clinical applications, poses substantial privacy and security risks. This paper aims to address the privacy and security concerns related to facial biometric data and support auxiliary diagnoses, in pursuit of which we developed Digital FaceDefender, an artificial intelligence-driven privacy safeguard solution. We constructed a diverse set of digitally synthesized Asian face avatars representing both sexes, spanning ages 5 to 85 years in 10-year increments, using 70,000 facial images and 13,061 Asian face images. Landmark data were separately extracted from both patient and avatar images. Affine transformations ensured spatial alignment, followed by color correction and Gaussian blur to enhance fusion quality. For auxiliary diagnosis, we established 95% CIs for pixel distances within the eye region on a cohort of 1163 individuals, serving as diagnostic benchmarks. Reidentification risk was assessed using the ArcFace model, applied to 2500 images reconstructed via Detailed Expression Capture and Animation (DECA). Finally, Cohen Kappa analyses (n=114) was applied to assess agreement between diagnostic benchmarks and ophthalmologists' evaluations. Compared to the DM method, Digital FaceDefender significantly reduced facial similarity scores (FDface vs raw images: 0.31; FLAME_FDface vs raw images: 0.09) and achieved zero Rank-1 accuracy in Pose #2-#3 and Pose #2-#5, with near-zero accuracy in Pose #4 (0.02) and Pose #5 (0.04), confirming lower reidentification risk. Cohen Kappa analysis demonstrated moderate agreement between our benchmarks and ophthalmologists' assessments for the left eye (κ=0.37) and right eye (κ=0.45; both P<.001), validating diagnostic reliability of the benchmarks. Furthermore, the user-friendly Digital FaceDefender platform has been established and is readily accessible for use. In summary, Digital FaceDefender effectively balances privacy protection and diagnostic use.
Medical subject headings
- Artificial Intelligence
- Facial Recognition
- Privacy
- Eye Diseases